10X GENOMICS INC-CLASS A (TXG:NASDAQ)
$22.97 -1.62 (-6.588%)
Analysed 10X GENOMICS INC-CLASS A (TXG:NASDAQ) News Sources
10x Genomics Stock Up on Atera Launch, Spatial Biology Scale Enhanced
20-04-2026
yahoo.com
Here's How Zimmer Biomet Is Placed Ahead of Q1 Earnings
20-04-2026
yahoo.com
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
19-04-2026
yahoo.com
3 Overrated Stocks We Keep Off Our Radar
17-04-2026
yahoo.com
10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026
15-04-2026
yahoo.com
Keys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologies Lead
13-04-2026
yahoo.com
Torex Gold Reports Q1 2026 Production Results
09-04-2026
yahoo.com
3 Small-Cap Stocks We Steer Clear Of
09-04-2026
yahoo.com
Torex Gold Welcomes Jacques Perron to Its Board of Directors
07-04-2026
yahoo.com
A Look At 10x Genomics (TXG) Valuation After Recent Share Price Momentum
05-04-2026
yahoo.com
What is the current price of 10X GENOMICS INC-CLASS A (TXG:NASDAQ)?
The current price of 10X GENOMICS INC-CLASS A (TXG:NASDAQ) is $22.97.
10X GENOMICS INC-CLASS A (TXG:NASDAQ) absolute price change since previous trading day?
The absolute price change of 10X GENOMICS INC-CLASS A (TXG:NASDAQ) since the previous trading day is $-1.62.
10X GENOMICS INC-CLASS A (TXG:NASDAQ) percentage price change since previous trading day?
The percentage price change of 10X GENOMICS INC-CLASS A (TXG:NASDAQ) since the previous trading day is -6.588%.
What is the most recent average sentiment score for 10X GENOMICS INC-CLASS A (TXG:NASDAQ)?
The most recent average sentiment score for 10X GENOMICS INC-CLASS A (TXG:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for 10X GENOMICS INC-CLASS A (TXG:NASDAQ)?
The most recent sentiment for 10X GENOMICS INC-CLASS A (TXG:NASDAQ) is .
SEC-8K** Filing Available For 10X GENOMICS INC-CLASS A (TXG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.